全文获取类型
收费全文 | 100045篇 |
免费 | 9227篇 |
国内免费 | 4777篇 |
专业分类
耳鼻咽喉 | 2125篇 |
儿科学 | 697篇 |
妇产科学 | 1807篇 |
基础医学 | 10906篇 |
口腔科学 | 3385篇 |
临床医学 | 7343篇 |
内科学 | 12029篇 |
皮肤病学 | 1998篇 |
神经病学 | 287篇 |
特种医学 | 4381篇 |
外国民族医学 | 122篇 |
外科学 | 16934篇 |
综合类 | 17240篇 |
现状与发展 | 23篇 |
预防医学 | 2163篇 |
眼科学 | 394篇 |
药学 | 5007篇 |
16篇 | |
中国医学 | 1239篇 |
肿瘤学 | 25953篇 |
出版年
2024年 | 184篇 |
2023年 | 1441篇 |
2022年 | 2936篇 |
2021年 | 3856篇 |
2020年 | 3352篇 |
2019年 | 3138篇 |
2018年 | 3068篇 |
2017年 | 3380篇 |
2016年 | 3808篇 |
2015年 | 4400篇 |
2014年 | 6522篇 |
2013年 | 5710篇 |
2012年 | 5859篇 |
2011年 | 6372篇 |
2010年 | 5143篇 |
2009年 | 5139篇 |
2008年 | 5379篇 |
2007年 | 5652篇 |
2006年 | 5290篇 |
2005年 | 4668篇 |
2004年 | 3743篇 |
2003年 | 3335篇 |
2002年 | 2865篇 |
2001年 | 2685篇 |
2000年 | 2332篇 |
1999年 | 1873篇 |
1998年 | 1694篇 |
1997年 | 1525篇 |
1996年 | 1324篇 |
1995年 | 1136篇 |
1994年 | 1032篇 |
1993年 | 709篇 |
1992年 | 637篇 |
1991年 | 538篇 |
1990年 | 460篇 |
1989年 | 396篇 |
1988年 | 389篇 |
1987年 | 312篇 |
1986年 | 247篇 |
1985年 | 273篇 |
1984年 | 229篇 |
1983年 | 159篇 |
1982年 | 184篇 |
1981年 | 158篇 |
1980年 | 150篇 |
1979年 | 125篇 |
1978年 | 89篇 |
1977年 | 58篇 |
1976年 | 47篇 |
1975年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
目的:重视尿路子宫内膜异位症,探讨其诊断,治疗方法,方法:对3例尿路子宫内膜异位症的临床表现和B超,CT,膀胱镜征象以及治疗方法进行分析。结果:术前明确诊断2例,术中发现1例,术后均病理证实,无复发,痊愈出院,疗效满意。结论:确诊需靠腔镜检查或手术探查,诊断应强调详细地询问病史,治疗方法的选择决定于子宫内膜异位症的部位。 相似文献
72.
食管癌放疗中二次模拟定位临床探讨 总被引:1,自引:0,他引:1
袁晔 《江苏大学学报(医学版)》2002,12(2):133-134
目的:探讨食管癌放疗中间再次定位的必要性和重要性。方法:我院放疗科自1998年10月-2001年3月对356例食管癌患者行单纯放疗或放疗加化疗,356例患者照射全过程都进行二次模拟定位(第一次模拟定位后照射30-40GY/15-20次后进行第2次模拟定位)。比较分析前后二次模拟定位靶中心移位的情况。结果;靶中心移位<0.5cm为157例,移位0.5-1.0cm为130例,移位>1.0cm为69例。全部靶中心移位达55.90%。食管肿瘤长度<5cm靶中心移位27例,5-8cm移位117例,病变长度>8cm移位55例,P<0.05;食管肿瘤发生于颈段,上胸段靶中心移位25例,而中、下段食管移位174例,P<0.01。结论:食管肿瘤外照射达到一定剂量时,靶中心会出现不同程度的移位,肿瘤长度越长靶中心移位会更明显, 肿瘤位置越小,移位亦显著。因此,我们对食管癌患者放疗全过程必需进行2到3次定位,这样才能保证靶中心的精确度,以达到预期治疗目的。 相似文献
73.
目的:探讨膀胱移行细胞癌中血管内皮生长因子(VEGF)的表达及其与临床病理指标的关系。方法:应用免疫组化方法对40例膀胱移行细胞癌及15例正常膀胱组织中VEGF进行检测。结果:正常膀胱移行上皮均为阴性表达;膀胱移行细胞癌中VEGF阳性表达24例,表达率为60%(24/40),明显高于正常膀胱组织(P<0.01),其中VEGF表达阳性率随膀胱癌病理分级、临床分期上升而升高,表达强度也随之增强(P<0.01)。结论:VEGF表达对膀胱移行细胞癌生物学行为有重要影响,VEGF有可能可作为判断膀胱癌生物学行为、转移潜能及预后指标。 相似文献
74.
HCC的早期诊断是其治疗的关键,HCC血清标志物的检测又为其诊断提供了有利的途径,并且操作简单,敏感性高和特异性强。目前常用的血清标志物为AFP、AFP变异体、AFP mRNA、AFU、GGT、DCP、AIF、GPC3等。这些标志物的联合使用有助于HCC的诊断及预后。 相似文献
75.
76.
77.
Su-Ping Sun Ye-Ning Jin Hong-Peng Yang Yi Wei Zhao Dong 《World journal of gastroenterology : WJG》2007,13(39)
AIM: To evaluate the relationship between changes in serum transforming growth factor β1 (TGFβ1) level and curative effect of radiotherapy (RT) in patients with esophageal carcinoma.METHODS: Ninety patients with histologically confirmed esophageal carcinoma were enrolled. Serum samples for TGFβ1 analysis were obtained before and at the end of RT. An enzyme-linked immunosorbent assay was used to measure serum TGFβ1 level. Multivariate analysis was performed to investigate the relationship between disease status and changes in serum TGFβ1 level.RESULTS: Serum TGFβ1 level in patients with esophageal carcinoma before RT was significantly higher than that in healthy controls (P < 0.001). At the end of RT, serum TGFβ1 level was decreased in 67.82% (59/87) of the patients. The overall survival rate at 1,3 and 5 years was 48.28% (42/87), 19.54% (17/87)and 12.64% (11/87), respectively. Main causes of death were local failure and regional lymph node metastasis.In patients whose serum TGFβ1 level decreased after RT,the survival rate at 1, 3 and 5 years was 61.02% (36/59),28.81% (17/59) and 18.64% (11/59), respectively. The survival rate at 1 year was 17.86% (5/28) in patients whose serum TGFβ1 level increased after RT, and all died within 18 mo (P < 0.01).CONCLUSION: Serum TGFβ1 level may be a useful marker for monitoring disease status after RT in patients with esophageal carcinoma. 相似文献
78.
Ho-Seong Han Jai Young Cho Yoo-Seok Yoon 《Journal of hepato-biliary-pancreatic sciences》2009,16(4):427-432
Many studies have recently reported on laparoscopic liver resection, although its development has been slow compared to laparoscopy in other fields. The indications for the location of laparoscopic liver resection have previously been limited to easily accessible lesions. Performing laparoscopic liver resection in the posterior and superior parts of the liver has been considered difficult due to inadequate exposure, the poor operative field and the difficulty with parenchymal dissection. Flexible endoscopy, high definition imaging and various kinds of equipment for parenchymal transection have been introduced for clinical use. In addition, much experience with this procedure has been accumulated at many centers. Accordingly, there are an increasing number of reports on laparoscopic liver resection in difficult locations. At our institution, the location of the tumor is no longer a limitation to laparoscopic liver resection. However, for safer laparoscopic liver resection, the patient positioning and trocar placement should be individualized according to the tumor location. The type of resection also may depend on the remaining liver’s functional capacity. We describe here the technical considerations for performing laparoscopic liver resection, including the technical considerations for performing laparoscopic liver resection for lesions located in the postero-superior segments of the liver. 相似文献
79.
膀胱肿瘤2350例临床病理学特点分析 总被引:1,自引:0,他引:1
目的 探讨膀胱肿瘤的发病现状、总体趋势和病理特点.方法 整理1980-2007年2350例膀胱肿瘤病理档案,分为1980-1989、1990-1999和2000-2007年3个时间段.应用SPSS 13.0软件分析3时间段患者性别、年龄及肿瘤组织学类型间的关系.结果 2350例膀胱肿瘤中男1854例,女496例.良性92例,恶性2258例,膀胱恶性肿瘤的发病人数逐年上升.发病高峰年龄从50~69岁推迟到60~79岁.1980-1989、1990-1999和2000-2007年3个时间段中男、女恶性肿瘤病例数分别为524例和113例(4.64:11 00)、589例和164例(3.59:1.00)、675例和193例(3.50:1.00),男性约为女性的3.80倍;3时间段男性发生膀胱尿路上皮癌年龄分别为(57.5±11.7)、(62.6±12.3)、(65.9±11.3)岁,女性分别为(58.7±13.6)、(60.7±12.1)、(65.8±12.0)岁,男女各年龄段分别比较差异有统计学意义(P<0.05).男性发生鳞状细胞癌、尿路上皮癌和腺癌年龄分别为(68.05±9.7)、(59.85±14.1)、(63.4±9.9)岁,差异有统计学意义(P相似文献
80.
G Gaitanis K Nomikos E Vava EC Alexopoulos ID Bassukas 《Journal of the European Academy of Dermatology and Venereology》2009,23(12):1427-1431
Background/aim Theoretical considerations support the combination of cryosurgery and topical imiquimod to treat basal cell carcinomas (BCC). The aim of the present study was to test the feasibility and efficacy of 'cryosurgery during continued imiquimod application' ('immunocryosurgery') to treat 'high-risk-for-recurrence' BCCs.
Methods Thirteen patients with 21 biopsy-proven tumours (4 of 21 relapses after prior surgery) were included. After 2–5 weeks (median, 3) of daily 5% imiquimod cream application, the tumours were treated by liquid N2 cryosurgery (spray, two cycles, 10–20 s) and imiquimod was continued for additional 2–12 weeks (median, 4). The outcome after at least 18 months of follow-up (18–24 months) is currently reported.
Results Nineteen of 21 tumours responded promptly to immunocryosurgery; two tumours required additional treatment cycles to clear. Thus, the clinical clearance rate was 100%. Only 1 of 21(5%) tumour relapsed after at least 18 months of follow-up (cumulative efficacy: 95%).
Conclusions 'Immunocryosurgery' is a promising non-surgical combination modality to treat 'high-risk-for-recurrence BCCs'. Initial evidence is suggestive of an at least additive effect of the two combined modalities. Further studies comparing immunocryosurgery directly with cryosurgery and imiquimod monotherapies will confirm the reported results. 相似文献
Methods Thirteen patients with 21 biopsy-proven tumours (4 of 21 relapses after prior surgery) were included. After 2–5 weeks (median, 3) of daily 5% imiquimod cream application, the tumours were treated by liquid N
Results Nineteen of 21 tumours responded promptly to immunocryosurgery; two tumours required additional treatment cycles to clear. Thus, the clinical clearance rate was 100%. Only 1 of 21(5%) tumour relapsed after at least 18 months of follow-up (cumulative efficacy: 95%).
Conclusions 'Immunocryosurgery' is a promising non-surgical combination modality to treat 'high-risk-for-recurrence BCCs'. Initial evidence is suggestive of an at least additive effect of the two combined modalities. Further studies comparing immunocryosurgery directly with cryosurgery and imiquimod monotherapies will confirm the reported results. 相似文献